About: Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline
Creator	Jones Hessell, Ann Kobie, James Sather, Noah Abid, Muhammad Nunley, Loren
Source	Medline; PMC
abstract	covid:683e32f166e03652d46fefac1360c5c80e8cd0d4#abstract
has issue date	2020-06-05(xsd:dateTime)
bibo:doi	10.3389/fimmu.2020.01294
bibo:pmid	32582221
has license	cc-by
sha1sum (hex)	683e32f166e03652d46fefac1360c5c80e8cd0d4
schema:url	https://doi.org/10.3389/fimmu.2020.01294
resource representing a document's title	Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline
has PubMed Central identifier	PMC7290157
has PubMed identifier	32582221
schema:publication	Front Immunol
resource representing a document's body	covid:683e32f166e03652d46fefac1360c5c80e8cd0d4#body_text
is schema:about of	named entity 'Immunity' named entity 'Natural' named entity 'comorbidities' named entity 'antiviral agent' named entity 'COVID-19' named entity 'ADE' named entity 'anti-microbial' named entity 'antibodies' named entity 'B-cells' named entity 'FcR' named entity 'T-cells' named entity 'CD8+ T-cells' named entity 'remdesivir' named entity 'ARDS' named entity 'viral entry' named entity 'initial phase' named entity 'viruses' named entity 'HCQ' named entity 'immunomodulatory' named entity 'FcR' named entity 'sample size' named entity 'SARS' named entity 'COVID' named entity 'Middle East respiratory syndrome' named entity 'memory T cells' named entity 'Hippocratic Oath' named entity 'Ebola' named entity 'immune response' named entity 'COVID' named entity 'COVID-19.' named entity 'SARS-CoV-1' named entity 'Zika' named entity 'ADE' named entity 'immune response' named entity 'severe acute respiratory syndrome' named entity 'antibody' named entity 'cross-immunity' named entity 'SARS-CoV-2' named entity 'clinical presentation' named entity 'COVID-19' named entity 'antigen' named entity 'humoral immune responses' named entity 'critical care' named entity 'ADE' named entity 'SARS-CoV-2' named entity 'Corona Virus Disease 2019' named entity 'convalescent plasma therapy' named entity 'immune responses' named entity 'IgM' named entity 'immunological' named entity 'cross-react' named entity 'Dengue' named entity 'comorbidities' named entity 'innate immune response' named entity 'randomized controlled trial' named entity 'COVID' named entity 'septic shock' named entity 'Fc receptors' named entity 'open-label' named entity 'SARS-CoV-1' named entity 'loss of life' named entity 'viremia' named entity 'antibodies' named entity 'Epidemiological studies' named entity 'natural immunity' named entity 'risk factors' named entity 'demographic factors' named entity 'HCQ' named entity 'infection' named entity 'MERS-CoV' named entity 'COVID' named entity 'open-label' named entity 'IgG' named entity 'SARS-CoV-2' named entity 'immune mechanisms' named entity 'anti-inflammatory' named entity 'infection'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software